Not available
Quote | T2 Biosystems Inc. (NASDAQ:TTOO)
Last: | $5.63 |
---|---|
Change Percent: | 1.65% |
Open: | $5.36 |
Close: | $5.63 |
High: | $5.7399 |
Low: | $5.232 |
Volume: | 96,857 |
Last Trade Date Time: | 05/22/2024 03:00:00 am |
News | T2 Biosystems Inc. (NASDAQ:TTOO)
2024-05-22 09:19:13 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript T2 Biosystems GAAP EPS of -$2.66, revenue of $2.06M T2 Biosystems shareholders vote to convert $15M CRG debt into equity Seeking Alpha’s Quant Rati...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...
Message Board Posts | T2 Biosystems Inc. (NASDAQ:TTOO)
Subject | By | Source | When |
---|---|---|---|
Got my tickets ready for the fireworks to | diskman | investorshub | 06/24/2023 1:23:51 AM |
As many have mentioned here, cheap shares are | Joe99999 | investorshub | 06/24/2023 12:36:42 AM |
Trying to move a bit now , lets | bakedog38 | investorshub | 06/23/2023 5:37:21 PM |
Lets goooo$$$$ | INFINITI | investorshub | 06/23/2023 5:29:29 PM |
Agreed !!! | bakedog38 | investorshub | 06/23/2023 5:21:04 PM |
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...
2024-05-17 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has closed its previously announced private placement for the purchase and sale of an aggregat...